Patents by Inventor Serena Reggi

Serena Reggi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for the administration of APOA1 and dosages
    Patent number: 11382348
    Abstract: The present invention relates to new compositions for the oral administration of apolipoproteins in the dimeric or multimeric form, with specific dosage regimens for use in the treatment of atherosclerosis.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: July 12, 2022
    Assignee: GRG GENE TECHNOLOGY SA
    Inventors: Roberto Giovannoni, Gabriele Romano, Nicola Fogher, Maria Rita Giuffre′, Mariateresa Pettinato, Serena Reggi
  • COMPOSITIONS FOR THE ADMINISTRATION OF APOA1 AND DOSAGES
    Publication number: 20190246677
    Abstract: The present invention relates to new compositions for the oral administration of apolipoproteins in the dimeric or multimeric form, with specific dosage regimens for use in the treatment of atherosclerosis.
    Type: Application
    Filed: July 31, 2017
    Publication date: August 15, 2019
    Applicant: GRG GENE TECHNOLOGY SA
    Inventors: Roberto GIOVANNONI, Gabriele ROMANO, Nicola FOGHER, Maria Rita GIUFFRE', Mariateresa PETTINATO, Serena REGGI
  • In-plant production of oligomeric (comprising three or more units) forms of human Apo A-1 protein muteins
    Patent number: 9637753
    Abstract: The present invention encompasses a method for the production of Apolipoproteins in dimeric and/or oligomeric forms (comprising three or more units) of muteins of the human ApoA-1 protein in plant seeds, novel variants of these proteins having an increased stability and capacity to transport cholesterol compared to the native ApoA-1 protein, expression systems for the production thereof, plants transformed capable of producing said proteins in seeds in dimeric and/or oligomeric forms, and nutraceutical derivatives of these plants.
    Type: Grant
    Filed: December 19, 2006
    Date of Patent: May 2, 2017
    Assignee: PLANTECHNO S.R.L.
    Inventors: Corrado Fogher, Serena Reggi, Kiril Perfanov
  • IN-PLANT PRODUCTION OF DIMERIC AND/OR OLIGOMERIC (COMPRISING THREE OR MORE UNITS) FORMS OF HUMAN APO A-1 PROTEIN MUTEINS
    Publication number: 20100168006
    Abstract: The present invention encompasses a method for the production of Apolipoproteins in dimeric and/or oligomeric forms (comprising three or more units) of muteins of the human ApoA-1 protein in plant seeds, novel variants of these proteins having an increased stability and capacity to transport cholesterol compared to the native ApoA-1 protein, expression systems for the production thereof, plants transformed capable of producing said proteins in seeds in dimeric and/or oligomeric forms, and nutraceutical derivatives of these plants.
    Type: Application
    Filed: December 19, 2006
    Publication date: July 1, 2010
    Inventors: Corrado Fogher, Serena Reggi, Kiril Perfanov
  • In- seed expression of lysosomal enzymes
    Publication number: 20060031965
    Abstract: The present invention relates to the production of transgenic plants able to express, in seed storage tissues, a lysosomal enzyme in enzymatically active form and in amounts appropriate to its use in enzyme replacement therapy. In particular, the present invention relates to plants and seeds containing this enzyme.
    Type: Application
    Filed: March 3, 2003
    Publication date: February 9, 2006
    Inventors: Corrado Fogher, Serena Reggi